Shanghai-based brain-computer interface (BCI) company StairMed, which claims to outperform Elon Musk’s Neuralink in certain ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

Kim Hak-kyun, CEO of Quantum Ventures Korea, was elected as the final candidate for the presidency of the Korea Venture Capital Association. Kim is the only candidate born in the 1970s among those ...

By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Hanwha Asset Management noted on the 7th that even when investing in the ‘PLUS High Dividend’ exchange-traded fund (ETF) that ...

Eli Lilly has lined up another deal in the radiopharmaceutical ... in a Series A financing led by Frazier Life Sciences, 5AM Ventures, and DCVC Bio, bringing the total raised to date to $82.5 ...

President Trump is likely to embrace the Medicare drug price negotiations that was initiated under the Biden administration, though the president could make some tweaks to put his own spin on it. The ...

As the first earnings season of 2025 unfolds, investors are likely analyzing financial reports to refine their portfolio strategies.

Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...